Kronos Worldwide, Inc. (KRO) Stock Price & Analysis
Kronos Worldwide, Inc. (KRO) closed at USD 7.7 on Wednesday, October 28, 2026, down 0.39% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 7.73; the Oct 28, 2026 session ranged USD 7.56–7.78 on volume of 216,074 shares. Market capitalization is $886.25M, with a 52-week range of USD 4.08–9.17 (NYQ). Source: Nexqual, retrieved October 29, 2026 at 11:31 UTC.
Also available as compact Markdown for AI agents: nexqual.com/KRO.md
Key facts (KRO)
- Last four reported quarters (through Jun 30, 2026): revenue $1.94B, net income -$109M (-5.6% margin) (SEC filings).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $99K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (2 analysts), mean target USD 8.5 (range 8–9).
- Total return with dividends: 1Y +62.2% vs S&P 500 +13.6%; 5Y -23.9% vs S&P 500 +79.8%.
- Next earnings: 2026-11-05, EPS estimate USD 0.19, revenue estimate $537M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (KRO)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.94B | $1.93B | $1.67B | $1.89B | $1.86B | $1.94B |
| Gross profit | $446M | $391M | $165M | $359M | $213M | — |
| Operating income | $187M | $160M | -$56.0M | $123M | -$36.5M | -$32.1M |
| Net income | $113M | $105M | -$49.1M | $86.2M | -$111M | -$109M |
| EPS (diluted) | $0.98 | $0.90 | -$0.43 | $0.75 | -$0.96 | — |
| Free cash flow | $148M | $18.5M | -$41.9M | $43.0M | -$40.4M | — |
| Gross margin | 23.0% | 20.3% | 9.9% | 19.0% | 11.5% | — |
| Operating margin | 9.6% | 8.3% | -3.4% | 6.5% | -2.0% | -1.7% |
| Net margin | 5.8% | 5.4% | -2.9% | 4.6% | -6.0% | -5.6% |
| Revenue growth | +18.3% | -0.5% | -13.7% | +13.2% | -1.5% | — |
| Cash + short-term investments | $406M | $328M | $195M | $107M | $33.2M | — |
| Total debt | $451M | $425M | $441M | $507M | $557M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (KRO)
P/S 0.5x · EV/EBITDA 46.7x · EV/Sales 0.7x · P/B 1.2x · Earnings yield -12.34% · Dividend yield (paid, TTM) 2.60% · Net debt $543M · EV $1.43B
P/E at fiscal year-ends: Dec 2024 13.0x.
Insider purchases (SEC Form 4, open-market, last ~7 months) (KRO)
1 purchase, $99K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-18 | Kramer Kevin B | Director | 14,601 | $99K | 6.75 | Too little history (no open-market trades in 2023 or 2024) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (KRO)
Consensus Hold (mean 3.00 on a 1–5 scale), 2 analysts; mean target USD 8.5 (low 8, high 9).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-25 | Deutsche Bank | Target raised | Buy | $6 → $9 |
Total return (dividends reinvested) (KRO)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +62.2% | -23.9% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | +62.5% | -5.3% |
| Volatility (annualized) | 58.5% | 47.3% |
| Max drawdown | -26.5% (Feb 2026→Mar 2026) | -72.2% (May 2022→Nov 2025) |
KRO earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| Aug 5, 2026 | Quarter ended Jun 30, 2026 | $0.13 | $0.07 | Beat +85.7% | +31.9% |
| May 6, 2026 | Quarter ended Mar 31, 2026 | −$0.04 | −$0.12 | Beat +66.7% | -9.6% |
| Mar 9, 2026 | Quarter ended Dec 31, 2025 | −$0.72 | −$0.23 | Miss −213.0% | -0.9% |
| Nov 6, 2025 | Quarter ended Sep 30, 2025 | −$0.32 | −$0.06 | Miss −433.3% | -7.0% |
| Aug 6, 2025 | — | — | — | — | -9.3% |
| May 7, 2025 | — | — | — | — | -3.1% |
| Mar 6, 2025 | — | — | — | — | -8.3% |
| Nov 6, 2024 | — | — | — | — | +4.6% |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
KRO recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 28, 2026 | 8-K | Regulation FD disclosure |
| Aug 5, 2026 | 8-K | Quarterly results; Regulation FD disclosure |
| Aug 5, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
KRO suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Louisiana Pigment Company | “LPC was operated as a manufacturing joint venture between us and Venator.” |
| Partner | Venator Investments | “LPC was operated as a manufacturing joint venture between us and Venator.” |
| Partner | Valhi | “We are a party to a tax sharing agreement with Contran and Valhi providing for the allocation of tax liabilities and tax payments as described in Note 1.” |
| Related party | Contran | “In addition, at December 31, 2025, we have a $53.7 million subordinated, unsecured term loan payable to a related party, Contran, due September 2029.” |
Quoted from the company's 10-K filed Mar 9, 2026.
KRO analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.19 | $0.04 | +380.1% | $537.3M | 2 |
| Next quarter (ends Dec 2026) | $0.12 | $0.00 | +$0.12 | $459.8M | 2 |
| Current fiscal year (ends Dec 2026) | $0.40 | $-0.08 | +$0.48 | $2.06B | 2 |
| Next fiscal year (ends Dec 2027) | $0.61 | $0.42 | +46.1% | $2.10B | 2 |
KRO options: expected move
Options price a move of about ±11.7% (±$0.90) by Nov 20, 2026, which includes earnings on Nov 5, 2026. Over the last 8 reports the stock moved ±9.3% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 22 | 57.5% | ±11.7% |
| Feb 19, 2027 | 113 | 58.1% | ±25.3% |
30-day implied volatility 57.3% vs 35.9% realized over the last 30 trading days. Put/call ratio (volume) —. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 29, 2026 at 11:31 UTC)
| Price | USD 7.7 |
|---|---|
| Change | ▼ 0.39% (down) |
| Previous Close | USD 7.73 |
| Open | USD 7.72 |
| Day Range | USD 7.56 – 7.78 |
| 52-Week Range | USD 4.08 – 9.17 |
| Volume | 216,074 shares |
| Market Cap | $886.25M |
| Exchange | NYQ |
Technical Analysis (KRO)
Nexqual's technical model rates KRO "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 29, 2026 at 11:31 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.19 (neutral) |
| vs SMA50 | Below (USD 8.05) |
| MACD | -0.08 (negative) |
Analyst Ratings (KRO)
Wall Street analysts rate KRO "Hold" based on 2 analysts, with a mean price target of USD 8.5 (range USD 8–9), per Nexqual as of October 29, 2026 at 11:31 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 8.5 |
| High Target | USD 9 |
| Low Target | USD 8 |
| Buy / Hold / Sell | 1 / 0 / 1 |
Earnings (KRO)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.19 |
| Revenue Estimate | $537.26M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.13 vs est 0.07 ▲ beat |
| 2026-03-31 | USD -0.04 vs est -0.12 ▲ beat |
| 2025-12-31 | USD -0.72 vs est -0.23 ▼ miss |
| 2025-09-30 | USD -0.32 vs est -0.06 ▼ miss |
Source: Nexqual, October 29, 2026 at 11:31 UTC.
Financials & Fundamentals (KRO)
| Total Revenue | $1.94B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +12.90% |
| Gross Margin | +12.01% |
| Operating Margin | +6.68% |
| Profit Margin | -5.63% |
| ROE | -13.69% |
| Debt / Equity | 0.78 |
| Current Ratio | 3.3 |
| Total Cash | $26.60M |
| Total Debt | $588.60M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | -$40.40M (-2.2% of revenue) |
Source: Nexqual, October 29, 2026 at 11:31 UTC.
Financial Health Score (KRO)
Nexqual rates Kronos Worldwide, Inc.'s overall financial health "Weak" across five dimensions, as of October 29, 2026 at 11:31 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Critical — Gross margin 12%, operating -2% (last 4 quarters to Jun 2026, SEC) |
| Balance Sheet | Mixed — $27M cash and investments vs $570M debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$40M (FY ended Dec 2025, 10-K), burning cash |
| Efficiency | Critical — ROE -15%, ROA -6.3% (last 4 quarters, SEC) |
Ownership (KRO)
| Insider Ownership | +81.27% |
|---|---|
| Institutional Ownership | +17.25% |
| Shares Outstanding | 115.10M |
| Float | 21.50M |
| Short % of Float | +5.10% |
Source: Nexqual, October 29, 2026 at 11:31 UTC.
Leadership (KRO)
Kronos Worldwide, Inc. is led by Brian W. Christian, President, CEO & Director, per Nexqual as of October 29, 2026 at 11:31 UTC.
| President, CEO & Director | Brian W. Christian |
|---|---|
| SVP & CFO | Bradley E. Troutman |
| Senior Vice President of Human Resources | Erica A. Austin |
| President of Americas | Benjamin R. Corona |
| Executive Vice President | Andrew B. Nace |
Major Backers & Investors (KRO)
Notable institutional backers of Kronos Worldwide, Inc. include Boston Partners, DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio, Trust for Professional Managers-Column Small Cap Select Fund, according to Nexqual as of October 29, 2026 at 11:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Boston Partners | 2.67% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 0.81% |
| Trust for Professional Managers-Column Small Cap Select Fund | 0.76% |
| Russell Investments Group, Ltd. | 0.58% |
| WisdomTree Trust-WisdomTree U.S. SmallCap Dividend Fund | 0.54% |
| AQR Capital Management, LLC | 0.53% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 2.48% |
| BlackRock | 1.49% |
| Vanguard Group | 0.85% |
| BNY Mellon | 0.69% |
Source: Nexqual, October 29, 2026 at 11:31 UTC.
From Kronos Worldwide, Inc.'s Latest SEC 10-K Filing (filed 2026-03-09)
Key Strengths & Strategy (as disclosed to the SEC)
- We expect to spend approximately $13 million on research and development in 2026.
- Our proprietary chloride production process is an important part of our technology and our business could be harmed if we fail to maintain confidentiality of our trade secrets used in this technology.
- We believe we are the leading seller of TiO2 in several countries, including Germany.
- As one of the few vertically integrated producers of sulfate process TiO2, we operate a rock ilmenite mine in Norway, which provided all of the feedstock for our sulfate process TiO2 plants in 2025.
Legal & Regulatory Risks (Item 1A, quoted)
- We may be subject to litigation, the disposition of which could have a material adverse effect on our results of operations.
- Environmental, health and safety laws and regulations may result in increased regulatory scrutiny which could decrease demand for our products, increase our manufacturing and compliance costs or obligations and result in unanticipated losses which could negatively impact our financial results or limit our ability to operate our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCPC | Balchem Corporation | USD 166.3 | ▼ 1.42% |
| SXT | Sensient Technologies Corporati | USD 131.59 | ▼ 0.23% |
| AXTA | Axalta Coating Systems Ltd. | USD 34.64 | ▲ 0.35% |
| EMN | Eastman Chemical Company | USD 66.67 | ▲ 0.83% |
| NEU | NewMarket Corp | USD 873.27 | ▼ 0.25% |
| WLK | Westlake Corporation | USD 65.83 | ▼ 0.51% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 11:31 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt